These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3284448)

  • 1. 5-Hydroxytryptamine receptor subtypes.
    Peroutka SJ
    Annu Rev Neurosci; 1988; 11():45-60. PubMed ID: 3284448
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonin receptor-mediated activation of adenylate cyclase in the neuroblastoma NCB.20: a novel 5-hydroxytryptamine receptor.
    Conner DA; Mansour TE
    Mol Pharmacol; 1990 May; 37(5):742-51. PubMed ID: 2338946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase.
    Gil DW; Wolfe BB
    J Pharmacol Exp Ther; 1985 Mar; 232(3):608-16. PubMed ID: 2579230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of serotonin-O-carboxymethyl-glycyl-tyrosinamide, a new selective indolic ligand for 5-hydroxytryptamine (5-HT)1B and 5-HT1D binding sites.
    Boulenguez P; Chauveau J; Segu L; Morel A; Delaage M; Lanoir J
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1360-5. PubMed ID: 1762084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Increase in binding affinity of the 5-HT receptor and decrease in 5-HT sensitive adenylate cyclase activity following prolonged exposure to 5-HT (author's transl)].
    Fillion G; Fillion MP; Rousselle JC
    J Physiol (Paris); 1981; 77(2-3):363-8. PubMed ID: 7288651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a 5-hydroxytryptamine receptor in mouse neuroblastoma N18TG2 cells.
    Unsworth CD; Molinoff PB
    J Pharmacol Exp Ther; 1994 Apr; 269(1):246-55. PubMed ID: 8169832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase.
    Plassat JL; Amlaiky N; Hen R
    Mol Pharmacol; 1993 Aug; 44(2):229-36. PubMed ID: 8394987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
    Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
    Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of an adenylyl cyclase-coupled 5-HT receptor in aplysia: comparison with mammalian 5-HT receptors.
    Cohen JE; Onyike CU; McElroy VL; Lin AH; Abrams TW
    J Neurophysiol; 2003 Mar; 89(3):1440-55. PubMed ID: 12611939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of lithium and antidepressants on monoaminergic receptors and receptor-coupled adenylate cyclase system in rat brain].
    Odagaki Y
    Hokkaido Igaku Zasshi; 1992 Mar; 67(2):247-58. PubMed ID: 1317819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin-activated signal transduction via serotonin receptors on Jurkat cells.
    Aune TM; Kelley KA; Ranges GE; Bombara MP
    J Immunol; 1990 Sep; 145(6):1826-31. PubMed ID: 2144010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Hydroxytryptamine-receptor subtypes.
    Brodde OE
    Clin Physiol Biochem; 1990; 8 Suppl 3():19-27. PubMed ID: 2132174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptors, receptor sensitivity, and receptor regulation in the CNS.
    Sulser F; Janowsky A
    Adv Biochem Psychopharmacol; 1982; 34():141-53. PubMed ID: 6291342
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding.
    Kilpatrick GJ; Jones BJ; Tyers MB
    Nature; 1987 Dec 24-31; 330(6150):746-8. PubMed ID: 3696238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of an adenylate cyclase-linked serotonin (5-HT) receptor system in a neuroblastoma x brain explant hybrid cell line (NCB-20) by opiates, prostaglandins, and alpha 2-adrenergic agonists.
    Berry-Kravis E; Dawson G
    Adv Biochem Psychopharmacol; 1983; 37():361-72. PubMed ID: 6138954
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of lipids in receptor mediated signal transduction.
    Banerjee P
    Indian J Biochem Biophys; 1993 Dec; 30(6):358-69. PubMed ID: 8005619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinction between adrenergic and serotonergic receptor subtypes: specificity of drugs and absence of cooperative interactions between adrenergic and serotonergic receptor binding sites.
    Leysen JE; Van Gompel P; Gommeren W
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S78-87. PubMed ID: 2459521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of lisuride, an ergot derivative, with serotonergic and dopaminergic receptors in rabbit brain.
    Rosenfeld MR; Makman MH
    J Pharmacol Exp Ther; 1981 Mar; 216(3):526-31. PubMed ID: 7205633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple receptors for serotonin in the rat brain.
    Hamon M; Nelson DL; Herbet A; Glowinski J
    Adv Biochem Psychopharmacol; 1980; 21():223-33. PubMed ID: 7376970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.